Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse
about
Antioxidant Cerium Oxide Nanoparticles in Biology and MedicineNeurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant MiceDefining the catalytic activity of nanoceria in the P23H-1 rat, a photoreceptor degeneration modelCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesNon-toxic retention of nanoceria in murine eyesCatalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injectionShifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organellesAbnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.Cerium oxide nanoparticles in cancerCerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death.Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationNanotechnology and nanotoxicology in retinopathy.Multi-Functional OCT Enables Longitudinal Study of Retinal Changes in a VLDLR Knockout Mouse Model.Preparation and Characterization Challenges to Understanding Environmental and Biological Impacts of Nanoparticles.Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.Functional role of inorganic trace elements in angiogenesis part III: (Ti, Li, Ce, As, Hg, Va, Nb and Pb).Regenerative nanomedicine and the treatment of degenerative retinal diseases.Cerium oxide nanoparticles: potential applications for cancer and other diseases.Nanoparticles in the ocular drug delivery.Cerium oxide nanoparticles: applications and prospects in nanomedicine.Next-generation therapeutic solutions for age-related macular degeneration.Nanocarriers of nanotechnology in retinal diseases.Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety.Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke.Integrated Approaches to Drug Discovery for Oxidative Stress-Related Retinal Diseases.Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion.Preparation, Characterization, and Preliminary In Vitro Testing of Nanoceria-Loaded Liposomes.Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria.Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism.The change in antioxidant properties of dextran-coated redox active nanoparticles due to synergetic photoreduction-oxidation.Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics.Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shapeDirect monitoring of the interaction between ROS and cerium dioxide nanoparticles in living cells
P2860
Q26747643-2E3B2A2B-C7EA-40F0-A517-B9AD6471F9D0Q27303147-0521DCB9-F145-481C-94DC-AF653D2766CFQ27310554-D777C3ED-91EA-41B2-A5B2-27CB57F9DC18Q28383937-91AD97F8-FCD6-470E-9E62-44962742283EQ28391505-749B0E70-9ED8-4E31-A3B7-5E75159B5221Q28395433-CD532B74-904E-4B39-A89B-C5C0DC13AC7EQ28396653-4EAEC4EB-3824-4E54-8264-39B16EB0B117Q30523799-4844ACD5-6723-400E-BCF7-11AEDD7FDAC0Q33706871-31C52347-589B-4669-A4D9-D4E2F7586932Q34153527-C09D382D-7E81-4822-B95E-FE6D141E3601Q34678965-22A207E2-416A-45D8-8E19-90D4FF173D32Q35224472-683D0E70-7447-4840-8FAC-DBC0B1878924Q35600266-83624CD6-52DE-4788-B391-7277DBC990A3Q36155334-F28B9C13-066C-4A9C-9D97-E0E920EE91FAQ36617879-44044E52-1936-4A90-80BD-C72FCB4F2430Q36772416-F977B542-5538-45C1-B78F-8C03BA663589Q37547846-3CC4A9B9-0965-4407-8121-C657D1DD6895Q37576114-3AAB41ED-2879-4868-9508-EF088110D25EQ37968572-3AA98B02-8DAF-468F-9185-423ECA8A9E83Q38097791-75934A6D-EBC3-49A5-A919-4A691A15103DQ38119238-2FDAD078-0B04-4F42-B5B6-D7A5E421EE63Q38132412-408BEDD6-5E25-4CC6-AE06-E1B47638D367Q38138089-533AD710-92E8-46B8-8729-2D68CB6F555DQ38282885-EF6AD987-F5E0-4997-8226-330D55D0EC0DQ38793842-0021CEE7-21D2-498A-B5AB-DD6E6A136264Q38910488-614612D6-DA0B-4044-A6BF-42CE9B142FD2Q39039446-6D2110D4-A35B-499F-83D8-4190D2C0EA72Q39154004-70D1CB4B-03D8-4331-A398-B631FAB680C9Q41666902-764F3989-A13F-43A7-9167-B325AB273E5DQ42019986-4A724ABC-9D3C-4BE8-B4BE-6BF606447BF8Q42720973-46A4EBF6-303A-4397-8DEB-BF044B1C9000Q46567213-EDCA3FEC-410F-4244-A9F8-EA53D44B415CQ49632281-2CE4DEDE-6D83-4BEB-BE29-A3B1AB218763Q51840951-50ECCCF2-EF1F-4480-8D71-3689CB08B54AQ53683300-00F103AF-410C-4EBC-A23C-E81D755EF3D3Q57376782-23EA4E28-4F82-430B-BB03-0AC6E1AD5DA1Q57376831-CAA3E956-E374-4D7C-84D7-D44E910FCE7A
P2860
Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@ast
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@en
type
label
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@ast
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@en
prefLabel
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@ast
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@en
P2093
P2860
P1433
P1476
Nanoceria inhibit the developm ...... on in the Vldlr knockout mouse
@en
P2093
James F McGinnis
Sudipta Seal
Xiaohong Zhou
P2860
P304
P356
10.1371/JOURNAL.PONE.0016733
P407
P577
2011-02-22T00:00:00Z